Thorp Clay
Director at Clearside Biomedical, Inc.; Director, 10% owner at PhaseBio Pharmaceuticals Inc
- Sold, on record
- $7.8M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Feb 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Clearside Biomedical, Inc.Director
- PhaseBio Pharmaceuticals IncDirector, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Clearside Biomedical, Inc.829,436 shares
- PhaseBio Pharmaceuticals Inc3,308 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Clearside Biomedical, Inc.Plan not statedOct 5, 2017 2017
Sold 35,000 shares at $8.57 ($300k)
Thorp Clay, Director, 10% owner
Sold 0.9% of holdings ($33.2M position)3.8M shares left1x usual sizeFiling
- 2 Form 4 sale Clearside Biomedical, Inc.Plan not statedNov 16, 2017 +42 days
Sold 35,000 shares at $7.00 ($245k)
Thorp Clay, Director, 10% owner
Sold 0.9% of holdings ($26.9M position)3.8M shares left1x usual sizeFiling
- 3 Form 4 sale Clearside Biomedical, Inc.Plan not statedDec 7, 2017 +21 days
Sold 35,000 shares at $6.22 ($218k)
Thorp Clay, Director, 10% owner
Sold 0.9% of holdings ($23.6M position)3.8M shares left1x usual sizeFiling
- 4 Form 4 sale Clearside Biomedical, Inc.UnusualMar 23, 2018 +106 days
Sold 138,861 shares at $12.21 ($1.7M)
Thorp Clay, Director, 10% owner
Sold 3.7% of holdings ($46M position)3.6M shares left4x usual sizeFiling
- 5 Form 4 sale Clearside Biomedical, Inc.UnusualMay 18, 2018 +56 days
Sold 161,139 shares at $13.08 ($2.1M)
Thorp Clay, Director, 10% owner
Sold 4.4% of holdings ($47.4M position)3.5M shares left4.6x usual sizeFiling
- 6 Form 4 sale PhaseBio Pharmaceuticals IncPlan not statedJun 18, 2019 +396 days
Sold 400 shares at $14.00 ($6k)
Thorp Clay, Director, 10% owner
Sold 0.1% of holdings ($5.8M position)416,418 shares leftFirst sale on recordFiling
- 7 Form 4 sale PhaseBio Pharmaceuticals IncPlan not statedJul 1, 2019 +13 days
Sold 2,908 shares at $14.00 ($41k)
Thorp Clay, Director, 10% owner
Sold 0.7% of holdings ($5.9M position)415,959 shares leftFiling
- 8 Form 4 sale Clearside Biomedical, Inc.Plan not statedFeb 10, 2021 +590 days
Sold 32,873 shares at $4.43 ($146k)
Thorp Clay, Director
Sold 0.9% of holdings ($15.4M position)3.4M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2021 | Feb 12, 2021 | Clearside Biomedical, Inc. | Director | Form 4 sale | 32,873 | $146k | 0.9% | Plan not stated | SEC |
| Jul 1, 2019 | Jul 3, 2019 | PhaseBio Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 2,908 | $41k | 0.7% | Plan not stated | SEC |
| Jun 18, 2019 | Jun 20, 2019 | PhaseBio Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 400 | $6k | 0.1% | Plan not stated | SEC |
| May 18, 2018 | May 21, 2018 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 161,139 | $2.1M | 4.4% | Unusual | SEC |
| Mar 23, 2018 | Mar 23, 2018 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 138,861 | $1.7M | 3.7% | Unusual | SEC |
| Dec 7, 2017 | Dec 7, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 35,000 | $218k | 0.9% | Plan not stated | SEC |
| Nov 16, 2017 | Nov 16, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 35,000 | $245k | 0.9% | Plan not stated | SEC |
| Oct 5, 2017 | Oct 5, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 35,000 | $300k | 0.9% | Plan not stated | SEC |
| Sep 15, 2017 | Sep 15, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 24,500 | $184k | 0.6% | Plan not stated | SEC |
| Aug 9, 2017 | Aug 9, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 24,500 | $185k | 0.6% | Plan not stated | SEC |
| May 19, 2017 | May 19, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 24,000 | $201k | 0.6% | Plan not stated | SEC |
| May 17, 2017 | May 17, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 44,485 | $384k | 1.1% | Plan not stated | SEC |
| Apr 19, 2017 | Apr 19, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 68,485 | $511k | 1.7% | Plan not stated | SEC |
| Mar 16, 2017 | Mar 17, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 68,485 | $450k | 1.7% | Plan not stated | SEC |
| Feb 22, 2017 | Feb 22, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 27,000 | $204k | 0.7% | Plan not stated | SEC |
| Feb 17, 2017 | Feb 17, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 41,485 | $315k | 1.0% | Plan not stated | SEC |
| Jan 20, 2017 | Jan 20, 2017 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 68,485 | $584k | 1.6% | Plan not stated | SEC |
| Jun 7, 2016 | Jun 7, 2016 | Clearside Biomedical, Inc. | Director, 10% owner | Form 4 sale | 138 | $966 | 0.0% | Plan not stated | SEC |